A controlled trial of methylene blue in severe depressive illness (1987)

Peer-Reviewed Study · Naylor GJ, Smith AH, Connelly P. · May 1987

Naylor GJ et al., 1987-05: Three-week placebo comparison of oral methylene blue 15 mg/day in severe depressive illness, reported as producing significantly greater improvement than placebo. The trial size is not stated in the abstract.

Methylene blue, 15 mg/day, was compared with placebo in treatment of severe depressive illness. The 3-week trial was designed to avoid bias by placebo response and also to avoid observer bias.

Naylor GJ et al., 1987-05: Three-week placebo comparison of oral methylene blue 15 mg/day in severe depressive illness, reported as producing significantly greater improvement than placebo. The trial size is not stated in the abstract. Study type: brief report (3 journal pages) of a placebo comparison; randomisation not stated in the abstract. N: NOT STATED in the accessible abstract; full text (Elsevier PDF) returned HTTP 403, so N, funder and conflicts could not be verified. Dose: 15 mg/day oral, 3 weeks. Comparator: placebo. Authors' own caveat, in the abstract: further clinical evaluation is essential. The full text is reported in secondary sources as a very small study, but no primary text confirming a specific N was obtained, so no N is asserted here. Also filed as MTK-27, MTC-070 (claims C11, C5, C7). Study type: controlled study.